Free Trial

TherapeuticsMD (TXMD) Insider Trading & Ownership

TherapeuticsMD logo
$1.12 -0.02 (-1.75%)
(As of 10:19 AM ET)

TherapeuticsMD (NASDAQ:TXMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2,040.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get TXMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling TherapeuticsMD stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TXMD Insider Buying and Selling by Quarter

TherapeuticsMD Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2024Cooper C CollinsDirectorBuy1,200$1.70$2,040.00  
(Data available from 1/1/2013 forward)

TXMD Insider Trading Activity - Frequently Asked Questions

The list of insiders at TherapeuticsMD includes Brian Bernick, Cooper C Collins, Gail K. Naughton, Marlan D Walker, Michael C Donegan, and Rubric Capital Management Lp. Learn more on insiders at TXMD.

2.30% of TherapeuticsMD stock is owned by insiders. Learn more on TXMD's insider holdings.

The following insider purchased TXMD shares in the last 24 months: Cooper C Collins ($2,040.00).

Insiders have purchased a total of 1,200 TXMD shares in the last 24 months for a total of $2,040.00 bought.

The following insiders have sold TXMD shares in the last 24 months: Marlan D Walker ($37,765.50), and Michael C Donegan ($15,324.52).

Insiders have sold a total of 18,620 TherapeuticsMD shares in the last 24 months for a total of $53,090.02 sold.

TherapeuticsMD Key Executives



This page (NASDAQ:TXMD) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners